Royalty Pharma (RPRX)

Royalty Pharma (RPRX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• RPRX last traded at $66.53, -0.97% on the day.
• Royalty Pharma: market cap $29.91B, P/E 27.6, revenue $2.54B over the last four quarters, next earnings 2026-11-04.
• Over the past year RPRX returned 80.10%; year to date 72.18%.

Updated 2026-11-02 22:04 UTC